As the hurricane season reaches its peak, and Hurricane Florence brings threats of catastrophic weather events and flooding to the eastern United States, preparation and sustained responses will be essential to prevent and respond to public health and infectious disease impacts that pose risks in a storm’s aftermath.

IDSA and HIVMA have been educating members of Congress on the devastating impact on patient care and the ID/HIV workforce of the CMS proposed policies to collapse outpatient evaluation and management (E/M) codes and dramatically cut reimbursement for the most complex visits.

IDSA, in cooperation with the National Board of Medical Examiners, has created a timed Practice Exam designed to prepare physicians for the ID Board Exam.

The House Energy & Commerce Committee is considering the draft Diagnostic Accuracy and Innovation Act (DAIA), a bill that would initiate Food and Drug Administration (FDA) regulation of laboratory developed tests (LDTs).

The House Energy & Commerce Committee is considering the draft Diagnostic Accuracy and Innovation Act (DAIA), a bill that would initiate Food and Drug Administration (FDA) regulation of laboratory developed tests (LDTs).

Members hosted congressional member and staff visits in the Bronx and New Jersey, offering insight into IDSA priorities including the urgent need for antibiotics research and development and the importance of federal funding for ID and HIV programs.

On a daily basis, IDSA spokespersons interview with media organizations across the country, providing facts, perspectives and important public health information about infectious diseases to the public.